254 related articles for article (PubMed ID: 32446716)
1. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites.
Téllez L; Ibáñez-Samaniego L; Pérez Del Villar C; Yotti R; Martínez J; Carrión L; Rodríguez de Santiago E; Rivera M; González-Mansilla A; Pastor Ó; Bermejo J; Bañares R; Albillos A
J Hepatol; 2020 Dec; 73(6):1404-1414. PubMed ID: 32446716
[TBL] [Abstract][Full Text] [Related]
2. Molecular Profiling of Decompensated Cirrhosis by a Novel MicroRNA Signature.
Garcia Garcia de Paredes A; Manicardi N; Tellez L; Ibañez L; Royo F; Bermejo J; Blanco C; Fondevila C; Fernandez Lanza V; Garcia-Bermejo L; Falcon-Perez JM; Bañares R; Gracia-Sancho J; Albillos A
Hepatol Commun; 2021 Feb; 5(2):309-322. PubMed ID: 33553977
[TBL] [Abstract][Full Text] [Related]
3. Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.
La Mura V; Tosetti G; Primignani M; Salerno F
World J Gastroenterol; 2015 Feb; 21(8):2265-8. PubMed ID: 25741132
[TBL] [Abstract][Full Text] [Related]
4. Non-selective beta-blockers in patients with ascites: The complex interplay among the liver, kidney and heart.
Téllez L; Albillos A
Liver Int; 2022 Apr; 42(4):749-761. PubMed ID: 35051310
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta-blockers on multiple haemodynamics in cirrhosis: A cross-over study by MR-imaging and hepatic vein catheterization.
Danielsen KV; Nabilou P; Wiese SS; Hove JD; Bendtsen F; Møller S
Liver Int; 2023 Oct; 43(10):2245-2255. PubMed ID: 37387503
[TBL] [Abstract][Full Text] [Related]
6. Beta adrenergic blockade and decompensated cirrhosis.
Reiberger T; Mandorfer M
J Hepatol; 2017 Apr; 66(4):849-859. PubMed ID: 27864004
[TBL] [Abstract][Full Text] [Related]
7. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices.
Scheiner B; Parada-Rodriguez D; Bucsics T; Schwabl P; Mandorfer M; Pfisterer N; Riedl F; Sieghart W; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T
Scand J Gastroenterol; 2017 Sep; 52(9):1008-1015. PubMed ID: 28532189
[TBL] [Abstract][Full Text] [Related]
8. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
Gastroenterology; 2014 Jun; 146(7):1680-90.e1. PubMed ID: 24631577
[TBL] [Abstract][Full Text] [Related]
9. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation.
Giannelli V; Roux O; Laouénan C; Manchon P; Ausloos F; Bachelet D; Rautou PE; Weiss E; Moreau R; Mebazaa A; Cohen-Solal A; Durand F; Francoz C
J Hepatol; 2020 Mar; 72(3):463-471. PubMed ID: 31622697
[TBL] [Abstract][Full Text] [Related]
10. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
[TBL] [Abstract][Full Text] [Related]
11. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Bosch J; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
13. Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients.
Bossen L; Krag A; Vilstrup H; Watson H; Jepsen P
Hepatology; 2016 Jun; 63(6):1968-76. PubMed ID: 26599983
[TBL] [Abstract][Full Text] [Related]
14. Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis.
Alvarado-Tapias E; Ardevol A; Garcia-Guix M; Montañés R; Pavel O; Cuyas B; Graupera I; Brujats A; Vilades D; Colomo A; Poca M; Torras X; Guarner C; Concepción M; Aracil C; Torres F; Villanueva C
J Hepatol; 2020 Oct; 73(4):829-841. PubMed ID: 32298768
[TBL] [Abstract][Full Text] [Related]
15. Optimal resting heart rate and ascites-related death in patients with cirrhosis and ascites using nonselective beta-blockers (ORCA).
Mingpun W; Sobhonslidsuk A; Chumnumwat S
Clin Transl Sci; 2024 Jan; 17(1):e13681. PubMed ID: 37950532
[TBL] [Abstract][Full Text] [Related]
16. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis.
Stadlbauer V; Wright GA; Banaji M; Mukhopadhya A; Mookerjee RP; Moore K; Jalan R
Gastroenterology; 2008 Jan; 134(1):111-9. PubMed ID: 18166350
[TBL] [Abstract][Full Text] [Related]
17. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M;
J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
[TBL] [Abstract][Full Text] [Related]
18. Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis.
Xu X; Gao F; Wang T; Yang Z; Zhao Q; Qi X
Ann Med; 2024 Dec; 56(1):2305935. PubMed ID: 38271554
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
Kim HY; So YH; Kim W; Ahn DW; Jung YJ; Woo H; Kim D; Kim MY; Baik SK
J Hepatol; 2019 Mar; 70(3):412-422. PubMed ID: 30389550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
